6[7]Rapheal Sj.High molecularweight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumor.Mod Pathol,1994,7:295
7[8]Miettinen M. Keratin subsets in papillary and follicular thyroid lesions: A paraffin section analysis with diagnosis implications. Vichows Arch,1997,431:407
4Ruud P,Fodstad O,Hovig E.Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells reaction assays used to detect micrometastatic tumor cells[].International Journal of Cancer.1999
6Wada N, Duh QY, Sugino K,et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas : frequecy, pattern of occurrence and recurrence, and optimal strategy for neck dissenction [J]. Ann Surg,2003,237:399 -407.
7武忠弼 杨光华主编.中华外科病理学[M].北京：人民卫生出版社,2002.646.
8Zannoni GF, Gallotta V, Legge F, et al. Pseudo-Meigs'syndrome associated with malignant struma ovarii: a case report [ J ]. Gynecol Oncol,2004,94( 1 ): 226 - 8.
9RotmanηPikielny P, Reynolds JC, Barker WC, et al. Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii [ J ]. J Clin Endocrinol Metab,2000,85(1) :237 -44.
10Mcdougall IR, Krasne D, Hanbery JW, et al. Metastatic malignant struma ovarii presenting as paraparesis from a spinal metastasis [J]. J Nucl Med,1989 ,30 : 407 -11.
